Lexaria Bioscience Corp. (LEXX)
10.52
-0.02
(-0.19%)
USD |
NASDAQ |
Aug 25, 09:46
Lexaria Bioscience Total Assets (Quarterly) : 4.781M for May 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 4.781M |
| February 28, 2026 | 6.487M |
| November 30, 2025 | 6.051M |
| August 31, 2025 | 4.175M |
| May 31, 2025 | 6.741M |
| February 28, 2025 | 8.678M |
| November 30, 2024 | 9.794M |
| August 31, 2024 | 8.868M |
| May 31, 2024 | 10.02M |
| February 29, 2024 | 6.352M |
| November 30, 2023 | 3.627M |
| August 31, 2023 | |
| May 31, 2023 | 5.240M |
| February 28, 2023 | 4.855M |
| November 30, 2022 | 6.214M |
| August 31, 2022 | 7.834M |
| May 31, 2022 | 9.138M |
| February 28, 2022 | 11.41M |
| November 30, 2021 | 11.75M |
| August 31, 2021 | 13.27M |
| May 31, 2021 | 10.55M |
| February 28, 2021 | 12.17M |
| November 30, 2020 | 2.174M |
| August 31, 2020 | 2.828M |
| May 31, 2020 | 3.320M |
| Date | Value |
|---|---|
| February 29, 2020 | 1.986M |
| November 30, 2019 | 2.746M |
| August 31, 2019 | 2.675M |
| May 31, 2019 | 3.457M |
| February 28, 2019 | 4.274M |
| November 30, 2018 | 3.544M |
| August 31, 2018 | 2.432M |
| May 31, 2018 | 2.709M |
| February 28, 2018 | 2.841M |
| November 30, 2017 | 2.497M |
| August 31, 2017 | 2.860M |
| May 31, 2017 | 3.144M |
| February 28, 2017 | 0.8691M |
| November 30, 2016 | 1.137M |
| August 31, 2016 | 0.5666M |
| May 31, 2016 | 0.3313M |
| February 29, 2016 | 0.3894M |
| November 30, 2015 | 0.4961M |
| August 31, 2015 | 0.7117M |
| May 31, 2015 | 1.199M |
| February 28, 2015 | 1.210M |
| November 30, 2014 | 2.251M |
| October 31, 2014 | |
| July 31, 2014 | 4.566M |
| April 30, 2014 | 4.838M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Target Group, Inc. (Canada) | 5.678M |
| InMed Pharmaceuticals, Inc. | 9.134M |
| NervGen Pharma Corp. | 63.57M |
| Milestone Pharmaceuticals, Inc. | 181.62M |
| Clearmind Medicine, Inc. | 14.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.4371M |
| Shareholders Equity (Quarterly) | 4.738M |
| Debt to Equity Ratio | 0.0183 |
| Current Ratio | 10.60 |
| Net Debt Paydown Yield | 0.05% |